PRVA
Privia Health Group, Inc.
Company overview
- Market capitalization
- $2.54B
- Employees
- 1,226
- Latest publication
- 2026-09-29
About Privia Health Group, Inc.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q2 20252025-06-30 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 632,630,000USD | 521,153,000USD | 460,900,000USD | 437,921,000USD | 415,243,000USD | 440,828,000USD | 417,282,000USD | 413,351,000USD |
| Selling And Marketing Expenses | 8,002,000USD | 6,805,000USD | 6,462,000USD | 7,047,000USD | 6,085,000USD | 6,249,000USD | 7,241,000USD | 5,956,000USD |
| General And Administrative Expenses | 39,658,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 620,857,000USD | 44,324,000USD | 42,719,000USD | 39,539,000USD | 40,027,000USD | 37,621,000USD | 36,200,000USD | 34,454,000USD |
| Operating Income | 11,773,000USD | 3,336,000USD | 5,248,000USD | 5,813,000USD | 823,000USD | 1,420,000USD | 5,536,000USD | 6,979,000USD |
| Total Other Income Expense Net | 4,978,000USD | 2,408,000USD | 2,774,000USD | 2,164,000USD | 2,984,000USD | 2,848,000USD | 2,894,000USD | 817,000USD |
| Depreciation And Amortization | 3,356,000USD | 2,583,000USD | 1,832,000USD | 1,797,000USD | 1,821,000USD | 1,772,000USD | 1,731,000USD | 1,690,000USD |
| Income Before Tax | 16,751,000USD | 5,744,000USD | 8,022,000USD | 7,977,000USD | 3,807,000USD | 4,268,000USD | 8,430,000USD | 7,796,000USD |
| Income Tax Expense | 7,017,000USD | 2,456,000USD | 2,655,000USD | 3,999,000USD | 751,000USD | 1,944,000USD | 2,488,000USD | 1,436,000USD |
| Net Income | 9,734,000USD | 2,687,000USD | 4,399,000USD | 3,535,000USD | 2,984,000USD | 2,838,000USD | 5,643,000USD | 7,274,000USD |
| Minority Interest | 686,000USD | -601,000USD | -968,000USD | -443,000USD | -72,000USD | 514,000USD | -299,000USD | -914,000USD |
| Cost Of Revenue | — | 473,493,000USD | 412,933,000USD | 392,569,000USD | 374,393,000USD | 401,787,000USD | 375,546,000USD | 371,918,000USD |
| Gross Profit | — | 47,660,000USD | 47,967,000USD | 45,352,000USD | 40,850,000USD | 39,041,000USD | 41,736,000USD | 41,433,000USD |
| Selling General Administrative | — | 37,519,000USD | 34,425,000USD | 30,695,000USD | 32,121,000USD | 29,600,000USD | 27,228,000USD | 26,808,000USD |
| Interest Income | — | 2,408,000USD | — | 2,164,000USD | 2,984,000USD | — | 2,894,000USD | — |
| Net Interest Income | — | 2,408,000USD | 2,774,000USD | 2,164,000USD | 2,984,000USD | 2,848,000USD | 2,894,000USD | 817,000USD |
| Tax Provision | — | 2,456,000USD | 2,655,000USD | 3,999,000USD | 751,000USD | 1,944,000USD | 2,488,000USD | 1,436,000USD |
| Net Income From Continuing Ops | — | 3,288,000USD | 5,367,000USD | 3,978,000USD | 3,056,000USD | 2,324,000USD | 5,942,000USD | 6,360,000USD |
| Ebit | — | 5,744,000USD | 8,022,000USD | 7,977,000USD | 3,807,000USD | 4,268,000USD | 8,430,000USD | 7,796,000USD |
| Ebitda | — | 8,327,000USD | 9,854,000USD | 9,774,000USD | 5,628,000USD | 6,040,000USD | 10,161,000USD | 9,486,000USD |
| Reconciled Depreciation | — | 2,583,000USD | 1,832,000USD | 1,797,000USD | 1,821,000USD | 1,772,000USD | 1,731,000USD | 1,690,000USD |
| Unclassified Operating Expenses | — | — | 1,832,000USD | 1,797,000USD | 1,821,000USD | 1,772,000USD | 1,731,000USD | 1,690,000USD |
| Interest Expense | — | — | — | — | — | 2,848,000,000USD | 2,894,000USD | 817,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | — | 7,274,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|
| Total Revenue | 817,075,000USD | 786,360,000USD |
| Cost Of Revenue | 734,493,000USD | 717,888,000USD |
| Gross Profit | 82,582,000USD | 68,472,000USD |
| Selling General Administrative | 44,016,000USD | 41,827,000USD |
| Selling And Marketing Expenses | 11,343,000USD | 9,156,000USD |
| Unclassified Operating Expenses | 1,843,000USD | 1,427,000USD |
| Total Operating Expenses | 57,202,000USD | 52,410,000USD |
| Operating Income | 25,380,000USD | 16,062,000USD |
| Interest Expense | 1,917,000USD | 6,910,000USD |
| Net Interest Income | -1,917,000USD | -6,910,000USD |
| Income Before Tax | 23,463,000USD | 9,152,000USD |
| Income Tax Expense | -7,441,000USD | 1,207,000USD |
| Tax Provision | -7,441,000USD | 1,207,000USD |
| Net Income | 31,244,000USD | 8,244,000USD |
| Net Income From Continuing Ops | 30,904,000USD | 7,945,000USD |
| Ebit | 25,380,000USD | 16,062,000USD |
| Ebitda | 27,223,000USD | 17,489,000USD |
| Depreciation And Amortization | 1,843,000USD | 1,427,000USD |
| Reconciled Depreciation | 1,830,000USD | 1,427,000USD |
| Total Other Income Expense Net | -1,917,000USD | -6,910,000USD |
| Minority Interest | -3,096,000USD | -2,756,000USD |
| Net Income Applicable To Common Shares | 31,244,000USD | 8,244,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,488,581,000USD | 1,417,892,000USD | 1,369,378,000USD | 1,350,987,000USD | 1,272,542,000USD | 1,183,538,000USD | 1,135,783,000USD | 1,145,565,000USD |
| Cash And Equivalents | 412,200,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 1,025,266,000USD | 966,022,000USD | 911,001,000USD | 970,926,000USD | 882,960,000USD | 886,467,000USD | 834,823,000USD | 853,753,000USD |
| Other Current Assets | 38,906,000USD | 32,822,000USD | 30,414,000USD | 30,533,000USD | 48,839,000USD | 28,409,000USD | 27,495,000USD | 22,797,000USD |
| Other Non Current Assets | 20,562,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 650,508,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 634,444,000USD | 601,298,000USD | 568,520,000USD | 582,914,000USD | 534,854,000USD | 470,810,000USD | 449,146,000USD | 479,473,000USD |
| Other Non Current Liabilities | 5,660,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 782,329,000USD | 753,059,000USD | 737,217,000USD | 709,124,000USD | 682,855,000USD | 659,436,000USD | 635,183,000USD | 614,886,000USD |
| Total Equity Including Noncontrolling Interest | 838,073,000USD | — | — | — | — | — | — | — |
| Net Receivables | 574,160,000USD | 513,676,000USD | 400,902,000USD | 499,041,000USD | 443,994,000USD | 388,727,000USD | 316,179,000USD | 408,959,000USD |
| Property Plant Equipment Net | 8,310,000USD | 8,691,000USD | 9,298,000USD | 6,333,000USD | 6,865,000USD | 5,733,000USD | 6,070,000USD | 6,744,000USD |
| Goodwill | 215,789,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 91,010,000USD | 529,276,000USD | 7,973,000USD | 10,216,000USD | 9,014,000USD | 7,952,000USD | 9,755,000USD | 6,935,000USD |
| Short Term Debt | 2,066,000USD | 2,114,000USD | 2,200,000USD | 2,563,000USD | 2,502,000USD | 2,386,000USD | 2,553,000USD | 2,580,000USD |
| Common Stock | 1,263,000USD | 1,257,000USD | 1,236,000USD | 1,229,000USD | 1,227,000USD | 1,214,000USD | 1,203,000USD | 1,199,000USD |
| Retained Earnings | -144,198,000USD | -153,246,000USD | -156,310,000USD | -165,461,000USD | -172,322,000USD | -175,009,000USD | -179,229,000,000USD | -183,628,000USD |
| Intangible Assets | — | 212,784,000USD | 215,919,000USD | 167,539,000USD | 170,140,000USD | 108,134,000USD | 109,807,000USD | 103,070,000USD |
| Total Liab | — | 611,988,000USD | 578,435,000USD | 588,226,000USD | 538,996,000USD | 474,012,000USD | 452,336,000USD | 483,383,000USD |
| Other Current Liab | — | 69,908,000USD | 558,347,000USD | 570,135,000USD | 523,338,000USD | 460,472,000USD | 449,133,692,000USD | 469,958,000USD |
| Capital Stock | — | 1,257,000USD | 1,236,000USD | 1,229,000USD | 1,227,000USD | 1,214,000USD | 1,203,000USD | 1,199,000USD |
| Good Will | — | 209,842,000USD | 209,842,000USD | 172,215,000USD | 172,215,000USD | 141,615,000USD | 141,615,000USD | 139,457,000USD |
| Cash | — | 419,524,000USD | 479,685,000USD | 441,352,000USD | 390,127,000USD | 469,331,000USD | 491,149,000USD | 421,997,000USD |
| Cash And Short Term Investments | — | 419,524,000USD | 479,685,000USD | 441,352,000USD | 390,127,000USD | 469,331,000USD | 491,149,000USD | 421,997,000USD |
| Net Debt | — | -410,503,000USD | -470,154,000USD | -435,117,000USD | -383,483,000USD | -463,896,000USD | -485,559,000USD | -415,820,000USD |
| Short Long Term Debt Total | — | 9,021,000USD | 9,531,000USD | 6,235,000USD | 6,644,000USD | 5,435,000USD | 5,590,000USD | 6,177,000USD |
| Property Plant Equipment Gross | — | 8,691,000USD | 16,842,000USD | 6,333,000USD | 6,865,000USD | 5,733,000USD | 12,876,000USD | 6,744,000USD |
| Common Stock Shares Outstanding | — | 130,879,000shares | 130,366,000shares | 128,776,684shares | 128,447,069shares | 127,752,527shares | 126,422,148shares | 125,751,006shares |
| Non Current Assets Total | — | 451,870,000USD | 458,377,000USD | 380,061,000USD | 389,582,000USD | 297,071,000USD | 310,955,000USD | 291,812,000USD |
| Non Current Liabilities Total | — | 10,690,000USD | 9,915,000USD | 5,312,000USD | 4,142,000USD | 3,202,000USD | 3,190,000USD | 3,910,000USD |
| Non Current Liabilities Other | — | 3,529,000USD | 2,584,000USD | 1,640,000USD | — | 153,000USD | 153,000USD | 313,000USD |
| Non Currrent Assets Other | — | 20,553,000USD | 21,044,000USD | 16,928,000USD | 16,650,000USD | 16,919,000USD | 17,085,000USD | 14,972,000USD |
| Net Working Capital | — | 364,724,000USD | 342,481,000USD | 388,012,000USD | 348,106,000USD | 415,657,000USD | 385,677,000USD | 374,280,000USD |
| Unclassified Non Current Liabilities | — | 7,161,000USD | 7,331,000USD | 3,672,000USD | 4,142,000USD | 3,049,000USD | 3,037,000USD | 3,597,000USD |
| Unclassified Equity | — | 903,791,000USD | 891,055,000USD | 872,127,000USD | 852,723,000USD | 832,017,000USD | 179,861,777,000USD | 796,116,000USD |
| Unclassified Non Current Assets | — | — | — | 17,046,000USD | 23,712,000USD | 24,670,000USD | 36,378,000USD | 27,569,000USD |
| Other Assets | — | — | — | — | — | — | -9,995,000USD | — |
| Short Term Investments | — | — | — | — | — | — | 490,657,851USD | — |
| Unclassified Current Assets | — | — | — | — | — | — | -490,657,851USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | — | -448,696,854,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,369,378,000USD | 1,135,783,000USD | 999,900,000USD | 792,813,000USD | 686,373,000USD | 328,969,000USD | 270,205,000USD | 249,485,000USD |
| Intangible Assets | 215,919,000USD | 109,807,000USD | 107,630,000USD | 57,387,000USD | 59,738,000USD | 5,980,000USD | 6,622,000USD | 7,265,000USD |
| Other Current Assets | 30,414,000USD | 27,495,000USD | 20,525,000USD | 14,366,000USD | 8,697,000USD | 6,333,000USD | 5,371,000USD | 5,218,000USD |
| Total Liab | 578,435,000USD | 452,336,000USD | 392,511,000USD | 273,764,000USD | 236,192,000USD | 185,317,000USD | 162,749,000USD | 163,445,000USD |
| Total Stockholder Equity | 737,217,000USD | 635,183,000USD | 561,437,000USD | 499,094,000USD | 426,872,000USD | 146,748,000USD | 110,212,000USD | 88,497,000USD |
| Other Current Liab | 558,347,000USD | 436,838,000USD | 376,027,000USD | 254,530,000USD | 183,720,000USD | 140,828,000USD | 111,320,000USD | 89,525,000USD |
| Common Stock | 1,236,000USD | 1,203,000USD | 1,182,000USD | 1,148,000USD | 1,078,000USD | 960,000USD | 959,000USD | 959,000USD |
| Capital Stock | 1,236,000USD | 1,203,000USD | 1,182,000USD | 1,148,000USD | 1,078,000USD | 960,000USD | 959,000USD | — |
| Retained Earnings | -156,310,000USD | -179,229,000USD | -193,614,000USD | -216,693,000USD | -208,108,000USD | -19,878,000USD | -51,122,000USD | -59,366,000USD |
| Good Will | 209,842,000USD | 141,615,000USD | 138,749,000USD | 126,938,000USD | 127,938,000USD | 118,663,000USD | 118,663,000USD | 118,663,000USD |
| Cash | 479,685,000USD | 491,149,000USD | 389,511,000USD | 347,992,000USD | 320,577,000USD | 84,633,000USD | 46,889,000USD | 39,108,000USD |
| Cash And Short Term Investments | 479,685,000USD | 491,149,000USD | 389,511,000USD | 347,992,000USD | 320,577,000USD | 84,633,000USD | 46,889,000USD | 39,108,000USD |
| Total Current Assets | 911,001,000USD | 834,823,000USD | 700,804,000USD | 551,962,000USD | 446,676,000USD | 190,084,000USD | 129,599,000USD | 115,486,000USD |
| Total Current Liabilities | 568,520,000USD | 449,146,000USD | 386,952,000USD | 264,274,000USD | 190,461,000USD | 146,938,000USD | 115,220,000USD | 101,322,000USD |
| Net Debt | -470,154,000USD | -485,559,000USD | -381,222,000USD | -336,489,000USD | -274,078,000USD | -50,974,000USD | -3,789,000USD | 27,895,000USD |
| Short Term Debt | 2,200,000USD | 2,553,000USD | 3,043,000USD | 3,013,000USD | 3,768,000USD | 875,000USD | 3,375,000USD | 7,132,000USD |
| Short Long Term Debt Total | 9,531,000USD | 5,590,000USD | 8,289,000USD | 11,503,000USD | 46,499,000USD | 33,659,000USD | 43,100,000USD | 67,003,000USD |
| Net Receivables | 400,902,000USD | 316,179,000USD | 290,768,000USD | 189,604,000USD | 117,402,000USD | 99,118,000USD | 77,339,000USD | 71,160,000USD |
| Accounts Payable | 7,973,000USD | 9,755,000USD | 7,882,000USD | 6,731,000USD | 2,973,000USD | 5,235,000USD | 525,000USD | 4,665,000USD |
| Property Plant Equipment Net | 9,298,000USD | 6,070,000USD | 8,937,000USD | 11,475,000USD | 14,136,000USD | 4,814,000USD | 5,622,000USD | 698,000USD |
| Property Plant Equipment Gross | 16,842,000USD | 12,876,000USD | 14,639,000USD | 11,475,000USD | 14,136,000USD | 4,814,000USD | 5,622,000USD | — |
| Common Stock Shares Outstanding | 128,890,000shares | 125,614,171shares | 124,686,067shares | 110,695,266shares | 107,837,741shares | 105,710,817shares | 105,710,817shares | 102,785,817shares |
| Non Current Assets Total | 458,377,000USD | 300,960,000USD | 299,096,000USD | 240,851,000USD | 239,697,000USD | 138,885,000USD | 140,606,000USD | 133,999,000USD |
| Non Current Liabilities Total | 9,915,000USD | 3,190,000USD | 5,559,000USD | 9,490,000USD | 45,731,000USD | 38,379,000USD | 47,529,000USD | 62,123,000USD |
| Non Current Liabilities Other | 2,584,000USD | 153,000USD | 313,000USD | 1,000,000USD | 3,000,000USD | 5,595,000USD | 4,923,000USD | — |
| Non Currrent Assets Other | 21,044,000USD | 17,085,000USD | 8,580,000USD | 4,683,000USD | 4,521,000USD | 4,475,000USD | 9,699,000USD | 7,373,000USD |
| Net Working Capital | 342,481,000USD | 385,677,000USD | 313,852,000USD | 287,688,000USD | 256,215,000USD | 43,146,000USD | 14,379,000USD | — |
| Unclassified Non Current Liabilities | 7,331,000USD | 3,037,000USD | 5,246,000USD | 7,490,000USD | 8,043,000USD | -5,595,000USD | -7,223,000USD | 57,171,000USD |
| Unclassified Equity | 891,055,000USD | 812,006,000USD | 752,687,000USD | 713,491,000USD | 632,824,000USD | 164,706,000USD | 160,400,000USD | 146,904,000USD |
| Unclassified Non Current Assets | — | 26,383,000USD | 35,200,000USD | -4,683,000USD | -4,521,000USD | -4,475,000USD | -9,699,000USD | -7,373,000USD |
| Current Deferred Revenue | — | — | -383,909,000USD | — | 43,012,000USD | 31,185,000USD | 27,939,000USD | — |
| Inventory | — | — | 1USD | 1USD | 1USD | — | 1USD | — |
| Accumulated Other Comprehensive Income | — | — | 0USD | 0USD | — | 0USD | -984,000USD | — |
| Other Liab | — | — | — | 1,000,000USD | 3,000,000USD | 5,595,000USD | 7,804,000USD | 2,252,000USD |
| Other Assets | — | — | — | 45,051,000USD | 37,885,000USD | 9,428,000USD | 9,699,000USD | 7,373,000USD |
| Net Tangible Assets | — | — | — | 314,769,000USD | 239,196,000USD | 22,105,000USD | -15,073,000USD | -37,431,000USD |
| Short Long Term Debt | — | — | — | — | 875,000USD | 875,000USD | 3,375,000USD | — |
| Long Term Debt | — | — | — | — | 31,688,000USD | 32,784,000USD | 39,725,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | -43,887,000USD | -32,060,000USD | -31,314,000USD | — |
| Deferred Long Term Liab | — | — | — | — | — | — | 2,300,000USD | 2,700,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 3,064,000USD | 9,151,000USD | 6,861,000USD | 3,288,000USD | 4,220,000USD | 5,367,000USD | 3,535,000USD | 3,467,000USD |
| Depreciation | 3,281,000USD | 2,657,000USD | 2,766,000USD | 2,583,000USD | 1,901,000USD | 1,832,000USD | 1,797,000USD | 1,818,000USD |
| Stock Based Compensation | 21,921,000USD | 71,049,151,000USD | 18,977,000USD | 18,849,000USD | 17,790,000USD | 15,279,000USD | 15,106,000USD | 14,391,000USD |
| Other Non Cash Items | 22,567,000USD | 14,427,000USD | 21,923,000USD | -69,218,000USD | 19,616,000USD | — | 15,549,000USD | 15,567,000USD |
| Change To Account Receivables | -112,774,000USD | 139,876,000USD | -55,047,000USD | -48,949,000USD | -72,548,000USD | 98,367,000USD | -38,904,000USD | -23,967,000USD |
| Change In Working Capital | -80,905,000USD | 99,731,000USD | 13,778,000USD | -17,707,000USD | -51,511,000USD | 51,134,000USD | 8,538,000USD | 10,582,000USD |
| Total Cash From Operating Activities | -49,465,000USD | 127,500,000USD | 51,994,000USD | 7,971,000USD | -24,061,000USD | 74,798,000USD | 33,154,000USD | 34,467,000USD |
| Capital Expenditures | -26,000USD | -1,200,000USD | -1,200,000USD | 0USD | 0USD | -15,000USD | -5,006,000USD | 0USD |
| Free Cash Flow | -49,491,000USD | 127,500,000USD | 50,794,000USD | 7,971,000USD | -24,061,000USD | 74,783,000USD | 33,154,000USD | 34,467,000USD |
| Total Cashflows From Investing Activities | -11,470,000USD | -91,312,000USD | -1,200,000USD | -89,058,000USD | — | -6,265,000USD | 653,000USD | 1,000,000USD |
| Total Cash From Financing Activities | 774,000USD | 2,145,000USD | 431,000USD | 1,883,000USD | 2,243,000USD | 619,000USD | 838,000USD | 749,000USD |
| Change In Cash | -60,161,000USD | 38,333,000USD | 51,225,000USD | -79,204,000USD | -21,818,000USD | 69,152,000USD | 34,645,000USD | 36,216,000USD |
| Begin Period Cash Flow | 479,685,000USD | 441,352,000USD | 390,127,000USD | 469,331,000USD | 491,149,000USD | 421,997,000USD | 387,352,000USD | 351,136,000USD |
| End Period Cash Flow | 419,524,000USD | 479,685,000USD | 441,352,000USD | 390,127,000USD | 469,331,000USD | 491,149,000USD | 421,997,000USD | 387,352,000USD |
| Unclassified Operating Cash Flow | -19,393,000USD | -71,047,617,000USD | -12,311,000USD | 70,176,000USD | -16,077,000USD | 1,186,000USD | -11,371,000USD | -11,358,000USD |
| Unclassified Investing Cash Flow | -11,444,000USD | -91,457,000USD | 2,400,000USD | — | — | — | 11,665,000USD | 6,006,000USD |
| Other Cashflows From Investing Activities | — | 1,345,000USD | -1,200,000USD | — | — | -15,000USD | -6,006,000USD | -5,006,000USD |
| Other Cashflows From Financing Activities | — | 1,114,000USD | 431,000USD | 1,883,000USD | 2,243,000USD | 619,000USD | 2,491,000USD | 1,749,000USD |
| Unclassified Financing Cash Flow | — | 1,031,000USD | — | — | — | — | -1,653,000USD | — |
| Investments | — | — | -1,200,000USD | -89,058,000USD | 0USD | -6,265,000USD | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 22,919,000USD | 14,385,000USD | 23,079,000USD | -12,064,000USD | -190,649,000USD | 30,904,000USD | 7,945,000USD | -4,189,000USD |
| Depreciation | 9,907,000USD | 7,268,000USD | 6,533,000USD | 4,571,000USD | 2,464,000USD | 1,830,000USD | 1,427,000USD | 1,072,000USD |
| Stock Based Compensation | 71,068,000,000USD | 56,680,000USD | 37,098,000USD | 67,359,000USD | 253,531,000USD | 484,000USD | 207,000USD | 1,941,000USD |
| Other Non Cash Items | 75,416,000USD | 59,339,000USD | 35,047,000USD | 687,000USD | 157,000USD | 134,000USD | 332,000USD | 147,000USD |
| Change To Account Receivables | -36,668,000USD | -19,824,000USD | -96,877,000USD | -72,202,000USD | -14,642,000USD | -21,779,000USD | -6,178,000USD | 320,000USD |
| Change In Working Capital | 44,291,000USD | 19,473,000USD | 8,661,000USD | -6,353,000USD | 17,966,000USD | 13,373,000USD | 13,731,000USD | 6,536,000USD |
| Total Cash From Operating Activities | 163,404,000USD | 109,282,000USD | 80,785,000USD | 47,196,000USD | 55,058,000USD | 38,891,000USD | 24,358,000USD | 5,249,000USD |
| Capital Expenditures | -1,200,000USD | -5,021,000USD | -113,000USD | -104,000USD | -547,000USD | -380,000USD | -5,709,000USD | -220,000USD |
| Free Cash Flow | 162,204,000USD | 104,261,000USD | 80,672,000USD | 47,092,000USD | 54,511,000USD | 38,511,000USD | 18,649,000USD | 5,029,000USD |
| Total Cashflows From Investing Activities | -181,570,000USD | -10,325,000USD | -48,006,000USD | -104,000USD | -32,775,000USD | -380,000USD | -5,709,000USD | -165,000USD |
| Total Cash From Financing Activities | 6,702,000USD | 2,681,000USD | 8,740,000USD | -19,677,000USD | 213,661,000USD | -767,000USD | -10,868,000USD | 15,356,000USD |
| Change In Cash | -11,464,000USD | 101,638,000USD | 41,519,000USD | 27,415,000USD | 235,944,000USD | 37,744,000USD | 7,781,000USD | 20,440,000USD |
| Begin Period Cash Flow | 491,149,000USD | 389,511,000USD | 347,992,000USD | 320,577,000USD | 84,633,000USD | 46,889,000USD | 39,108,000USD | 18,668,000USD |
| End Period Cash Flow | 479,685,000USD | 491,149,000USD | 389,511,000USD | 347,992,000USD | 320,577,000USD | 84,633,000USD | 46,889,000USD | 39,108,000USD |
| Other Cashflows From Investing Activities | 1,345,000USD | -5,021,000USD | — | -125,000USD | -32,228,000USD | — | — | — |
| Other Cashflows From Financing Activities | 1,114,000USD | 1,653,000USD | 3,705,000USD | 125,000USD | -9,149,000USD | 108,000USD | 34,382,000USD | 106,000USD |
| Unclassified Operating Cash Flow | -71,057,129,000USD | -47,863,000USD | -29,633,000USD | -7,004,000USD | -28,411,000USD | -7,834,000USD | — | — |
| Unclassified Investing Cash Flow | -181,715,000USD | 11,695,000USD | -9,930,000USD | — | 32,775,000USD | — | 5,709,000USD | — |
| Unclassified Financing Cash Flow | 5,588,000USD | 1,028,000USD | 5,035,000USD | — | 8,862,000USD | — | -35,000,000USD | — |
| Investments | — | -11,978,000USD | -37,963,000USD | -104,000USD | -32,775,000USD | -380,000USD | -5,709,000USD | -165,000USD |
| Net Borrowings | — | 0USD | 0USD | -33,250,000USD | -875,000USD | -875,000USD | -10,250,000USD | 15,250,000USD |
| Issuance Of Capital Stock | — | — | 0USD | -1,000USD | 223,685,000USD | 0USD | 0USD | — |
| Change To Liabilities | — | — | — | 4,852,000USD | 1,262,000USD | 4,710,000USD | -4,141,000USD | -983,000USD |
| Sale Purchase Of Stock | — | — | — | 13,573,000USD | 214,823,000USD | — | — | — |
| Cash And Cash Equivalents Changes | — | — | — | 27,415,000USD | 235,944,000USD | — | — | — |
| Change To Inventory | — | — | — | — | -1,262,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Capitated Revenue | 95,150,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Care Management Fee PMPM | 20,733,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | FFSAdministrative Services | 33,222,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | FFSPatient Care | 412,640,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Other Revenue | 1,965,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Shared Savings | 68,920,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Capitated Revenue | 86,148,000 | USD | 0001759655-26-000029 |
| Q1 2026Quarterly · 2026-03-31 | Product | Care Management Fee PMPM | 17,865,000 | USD | 0001759655-26-000029 |
| Q1 2026Quarterly · 2026-03-31 | Product | FFSAdministrative Services | 31,403,000 | USD | 0001759655-26-000029 |
| Q1 2026Quarterly · 2026-03-31 | Product | FFSPatient Care | 391,133,000 | USD | 0001759655-26-000029 |
| Q1 2026Quarterly · 2026-03-31 | Product | Other Revenue | 2,336,000 | USD | 0001759655-26-000029 |
| Q1 2026Quarterly · 2026-03-31 | Product | Shared Savings | 74,962,000 | USD | 0001759655-26-000029 |
| Q4 2025Quarterly · 2025-12-31 | Product | Capitated Revenue | 71,351,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Care Management Fee PMPM | 20,026,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | FFSAdministrative Services | 36,030,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | FFSPatient Care | 364,406,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Other Revenue | 2,472,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Shared Savings | 46,888,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Administrative Service | 3,500,000 | USD | 0001759655-26-000010 |
| FY 2025Yearly · 2025-12-31 | Product | Capitated Revenue | 308,458,000 | USD | 0001759655-26-000010 |
| FY 2025Yearly · 2025-12-31 | Product | Care Management Fee PMPM | 73,138,000 | USD | 0001759655-26-000010 |
| FY 2025Yearly · 2025-12-31 | Product | FFSAdministrative Services | 137,017,000 | USD | 0001759655-26-000010 |
| FY 2025Yearly · 2025-12-31 | Product | FFSPatient Care | 1,360,235,000 | USD | 0001759655-26-000010 |
| FY 2025Yearly · 2025-12-31 | Product | Other Revenue | 9,179,000 | USD | 0001759655-26-000010 |
| FY 2025Yearly · 2025-12-31 | Product | Shared Savings | 234,815,000 | USD | 0001759655-26-000010 |
| Q3 2025Quarterly · 2025-09-30 | Product | Capitated Revenue | 90,906,000 | USD | 0001759655-25-000110 |
| Q3 2025Quarterly · 2025-09-30 | Product | Care Management Fee PMPM | 20,992,000 | USD | 0001759655-25-000110 |
| Q3 2025Quarterly · 2025-09-30 | Product | FFSAdministrative Services | 33,616,000 | USD | 0001759655-25-000110 |
| Q3 2025Quarterly · 2025-09-30 | Product | FFSPatient Care | 352,604,000 | USD | 0001759655-25-000110 |
| Q3 2025Quarterly · 2025-09-30 | Product | Other Revenue | 2,307,000 | USD | 0001759655-25-000110 |
| Q3 2025Quarterly · 2025-09-30 | Product | Shared Savings | 79,994,000 | USD | 0001759655-25-000110 |
| Q2 2025Quarterly · 2025-06-30 | Product | Capitated Revenue | 75,511,000 | USD | 0001759655-25-000093 |
| Q2 2025Quarterly · 2025-06-30 | Product | Care Management Fee PMPM | 16,919,000 | USD | 0001759655-25-000093 |
| Q2 2025Quarterly · 2025-06-30 | Product | FFSAdministrative Services | 35,116,000 | USD | 0001759655-25-000093 |
| Q2 2025Quarterly · 2025-06-30 | Product | FFSPatient Care | 331,464,000 | USD | 0001759655-25-000093 |
| Q2 2025Quarterly · 2025-06-30 | Product | Other Revenue | 2,122,000 | USD | 0001759655-25-000093 |
| Q2 2025Quarterly · 2025-06-30 | Product | Shared Savings | 60,021,000 | USD | 0001759655-25-000093 |
| Q1 2025Quarterly · 2025-03-31 | Product | Capitated Revenue | 70,690,000 | USD | 0001759655-26-000029 |
| Q1 2025Quarterly · 2025-03-31 | Product | Care Management Fee PMPM | 15,201,000 | USD | 0001759655-26-000029 |
| Q1 2025Quarterly · 2025-03-31 | Product | FFSAdministrative Services | 32,255,000 | USD | 0001759655-26-000029 |
| Q1 2025Quarterly · 2025-03-31 | Product | FFSPatient Care | 311,761,000 | USD | 0001759655-26-000029 |
| Q1 2025Quarterly · 2025-03-31 | Product | Other Revenue | 2,278,000 | USD | 0001759655-26-000029 |
| Q1 2025Quarterly · 2025-03-31 | Product | Shared Savings | 47,912,000 | USD | 0001759655-26-000029 |
| Q4 2024Quarterly · 2024-12-31 | Product | Capitated Revenue | 51,852,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Care Management Fee PMPM | 16,240,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | FFSAdministrative Services | 33,526,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | FFSPatient Care | 312,294,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Other Revenue | 2,506,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Shared Savings | 44,482,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Administrative Service | 1,800,000 | USD | 0001759655-26-000010 |
| FY 2024Yearly · 2024-12-31 | Product | Capitated Revenue | 212,987,000 | USD | 0001759655-26-000010 |
| FY 2024Yearly · 2024-12-31 | Product | Care Management Fee PMPM | 64,066,000 | USD | 0001759655-26-000010 |
| FY 2024Yearly · 2024-12-31 | Product | FFSAdministrative Services | 125,431,000 | USD | 0001759655-26-000010 |
| FY 2024Yearly · 2024-12-31 | Product | FFSPatient Care | 1,146,156,000 | USD | 0001759655-26-000010 |
| FY 2024Yearly · 2024-12-31 | Product | Other Revenue | 8,548,000 | USD | 0001759655-26-000010 |
| FY 2024Yearly · 2024-12-31 | Product | Shared Savings | 179,202,000 | USD | 0001759655-26-000010 |
| Q3 2024Quarterly · 2024-09-30 | Product | Capitated Revenue | 53,393,000 | USD | 0001759655-25-000110 |
| Q3 2024Quarterly · 2024-09-30 | Product | Care Management Fee PMPM | 21,060,000 | USD | 0001759655-25-000110 |
| Q3 2024Quarterly · 2024-09-30 | Product | FFSAdministrative Services | 30,697,000 | USD | 0001759655-25-000110 |
| Q3 2024Quarterly · 2024-09-30 | Product | FFSPatient Care | 283,278,000 | USD | 0001759655-25-000110 |
| Q3 2024Quarterly · 2024-09-30 | Product | Other Revenue | 2,055,000 | USD | 0001759655-25-000110 |
| Q3 2024Quarterly · 2024-09-30 | Product | Shared Savings | 47,438,000 | USD | 0001759655-25-000110 |
| FY 2023Yearly · 2023-12-31 | Product | Administrative Service | 2,700,000 | USD | 0001759655-26-000010 |
| FY 2023Yearly · 2023-12-31 | Product | Capitated Revenue | 338,729,000 | USD | 0001759655-26-000010 |
| FY 2023Yearly · 2023-12-31 | Product | Care Management Fee PMPM | 50,519,000 | USD | 0001759655-26-000010 |
| FY 2023Yearly · 2023-12-31 | Product | FFSAdministrative Services | 113,154,000 | USD | 0001759655-26-000010 |
| FY 2023Yearly · 2023-12-31 | Product | FFSPatient Care | 976,688,000 | USD | 0001759655-26-000010 |
| FY 2023Yearly · 2023-12-31 | Product | Other Revenue | 8,504,000 | USD | 0001759655-26-000010 |
| FY 2023Yearly · 2023-12-31 | Product | Shared Savings | 170,143,000 | USD | 0001759655-26-000010 |
| FY 2022Yearly · 2022-12-31 | Product | Administrative Service | 2,700,000 | USD | 0001759655-24-000022 |
| FY 2022Yearly · 2022-12-31 | Product | Capitated Revenue | 218,463,000 | USD | 0001759655-24-000022 |
| FY 2022Yearly · 2022-12-31 | Product | Care Management Fee PMPM | 35,541,000 | USD | 0001759655-24-000022 |
| FY 2022Yearly · 2022-12-31 | Product | FFSAdministrative Services | 94,929,000 | USD | 0001759655-24-000022 |
| FY 2022Yearly · 2022-12-31 | Product | FFSPatient Care | 869,165,000 | USD | 0001759655-24-000022 |
| FY 2022Yearly · 2022-12-31 | Product | Other Revenue | 5,947,000 | USD | 0001759655-24-000022 |
| FY 2022Yearly · 2022-12-31 | Product | Shared Savings | 132,615,000 | USD | 0001759655-24-000022 |
| FY 2021Yearly · 2021-12-31 | Product | Administrative Service | 0 | USD | 0001759655-24-000022 |
| FY 2021Yearly · 2021-12-31 | Product | Capitated Revenue | 0 | USD | 0001759655-24-000022 |
| FY 2021Yearly · 2021-12-31 | Product | Care Management Fee PMPM | 36,503,000 | USD | 0001759655-24-000022 |
| FY 2021Yearly · 2021-12-31 | Product | FFSAdministrative Services | 68,805,000 | USD | 0001759655-24-000022 |
| FY 2021Yearly · 2021-12-31 | Product | FFSPatient Care | 772,482,000 | USD | 0001759655-24-000022 |
| FY 2021Yearly · 2021-12-31 | Product | Other Revenue | 5,414,000 | USD | 0001759655-24-000022 |
| FY 2021Yearly · 2021-12-31 | Product | Shared Savings | 83,016,000 | USD | 0001759655-24-000022 |
| FY 2020Yearly · 2020-12-31 | Product | Administrative Service | 0 | USD | 0001759655-23-000026 |
| FY 2020Yearly · 2020-12-31 | Product | Capitated Revenue | 0 | USD | 0001759655-23-000026 |
| FY 2020Yearly · 2020-12-31 | Product | Care Management Fee PMPM | 26,766,000 | USD | 0001759655-23-000026 |
| FY 2020Yearly · 2020-12-31 | Product | FFSAdministrative Services | 58,278,000 | USD | 0001759655-23-000026 |
| FY 2020Yearly · 2020-12-31 | Product | FFSPatient Care | 647,314,000 | USD | 0001759655-23-000026 |
| FY 2020Yearly · 2020-12-31 | Product | Other Revenue | 18,303,000 | USD | 0001759655-23-000026 |
| FY 2020Yearly · 2020-12-31 | Product | Shared Savings | 66,414,000 | USD | 0001759655-23-000026 |
| FY 2019Yearly · 2019-12-31 | Product | Care Management Fee PMPM | 18,547,000 | USD | 0001759655-22-000032 |
| FY 2019Yearly · 2019-12-31 | Product | FFSAdministrative Services | 48,510,000 | USD | 0001759655-22-000032 |
| FY 2019Yearly · 2019-12-31 | Product | FFSPatient Care | 676,157,000 | USD | 0001759655-22-000032 |
| FY 2019Yearly · 2019-12-31 | Product | Other Revenue | 3,292,000 | USD | 0001759655-22-000032 |
| FY 2019Yearly · 2019-12-31 | Product | Shared Savings | 39,854,000 | USD | 0001759655-22-000032 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.